4.75
前日終値:
$4.42
開ける:
$4.38
24時間の取引高:
897.15K
Relative Volume:
0.91
時価総額:
$277.43M
収益:
-
当期純損益:
$-96.66M
株価収益率:
-2.2093
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+17.00%
1か月 パフォーマンス:
+12.29%
6か月 パフォーマンス:
-60.65%
1年 パフォーマンス:
-52.17%
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
OLMA
Olema Pharmaceuticals Inc
|
4.75 | 277.43M | 0 | -96.66M | -83.73M | -2.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-04-02 | 開始されました | Goldman | Buy |
2024-01-30 | 開始されました | Citigroup | Buy |
2023-07-21 | 開始されました | Oppenheimer | Outperform |
2023-05-05 | 開始されました | CapitalOne | Overweight |
2023-02-22 | 開始されました | Credit Suisse | Outperform |
2022-07-06 | 再開されました | Canaccord Genuity | Buy |
2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
2021-12-07 | 再開されました | Cowen | Outperform |
2020-12-14 | 開始されました | Canaccord Genuity | Buy |
2020-12-14 | 開始されました | Cowen | Outperform |
2020-12-14 | 開始されました | JP Morgan | Overweight |
2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Holdings Boosted by Vanguard Group Inc. - MarketBeat
Alliancebernstein L.P. Increases Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Franklin Resources Inc. Has $1.60 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Vanguard Group Inc. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Alliancebernstein L.P. Has $1.83 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
American Century Companies Inc. Reduces Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Wellington Management Group LLP Purchases 522,799 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
KLP Kapitalforvaltning AS Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA) - Yahoo Finance
Wellington Management Group LLP Has $8.84 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - The AM Reporter
Schroder Investment Management Group Increases Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market - Seeking Alpha
Pictet Asset Management Holding SA Has $10.98 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
HighTower Advisors LLC Invests $510,000 in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
10,352 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Bought by Teacher Retirement System of Texas - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Expands Team: 5 Key Hires Receive Equity Compensation Package - Stock Titan
Top Premarket Decliners - MarketScreener
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st
JPMorgan Chase & Co. Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat
Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - Defense World
Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire
Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan
What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat
What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat
Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
HC Wainwright Issues Optimistic Estimate for OLMA Earnings - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World
FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):